Bayer Price to Sales Ratio 2010-2023 | BAYRY

Historical PS ratio values for Bayer (BAYRY) over the last 10 years. The current P/S ratio for Bayer as of April 25, 2024 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Bayer P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
0.00 nan
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $0.000B $51.553B
Bayer AG is a life science company with core competencies in the areas of health care and agriculture. With the company's focus completely on the Life Science businesses, a new organizational structure was introduced effective Jan 1, 2016. Bayer Group now comprise exclusively of the Life Science businesses. The company started reporting in three segments ' Pharmaceuticals, Consumer Health and Crop Science ' from the third quarter of 2019. Both Animal Health and Currenta were reported as discontinued operations in the quarter. The company acquired U.S. seed giant Monsanto in June, 2018. With the acquisition, Bayer now has the strongest portfolio of seed and crop protection products for a wide range of crops and indications, the best research and development platform and the leading digital farming business.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $695.710B 115.85
Novo Nordisk (NVO) Denmark $566.147B 46.64
Johnson & Johnson (JNJ) United States $357.925B 14.20
Merck (MRK) United States $321.695B 84.67
AbbVie (ABBV) United States $297.115B 15.10
AstraZeneca (AZN) United Kingdom $220.752B 19.56
Novartis AG (NVS) Switzerland $201.027B 14.25
Pfizer (PFE) United States $148.755B 14.35
Sanofi (SNY) $117.905B 10.62
Innoviva (INVA) United States $0.959B 6.77